PubRank

D L Fine

Author PubWeight™ 44.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988 9.96
2 New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 1989 4.04
3 Development of human tumor cell line panels for use in disease-oriented drug screening. Prog Clin Biol Res 1988 1.95
4 Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures. J Natl Cancer Inst 1974 1.62
5 In vitro system for production of mouse mammary tumor virus. Appl Microbiol 1974 1.54
6 Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J Natl Cancer Inst 1975 1.44
7 Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins. Virology 1978 1.35
8 Propagation of mouse mammary tumor cell lines and production of mouse mammary tumor virus in a serum-free medium. In Vitro 1976 1.18
9 Immunological characterization of the low-molecular-weight DNA binding protein of mouse mammary tumor virus. Int J Cancer 1978 1.06
10 Comparative large-scale propagation of retroviruses from Old World (Mason-Pfizer monkey virus) and New World (squirrel monkey virus) primates. In Vitro 1978 1.00
11 Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence. Cancer Res 1976 0.98
12 Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res 1988 0.97
13 Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Cancer Res 1976 0.96
14 Coexistence of the mouse mammary tumor virus (MMTV) major glycoprotein and natural antibodies to MMTV in sera of mammary tumor-bearing mice. Virology 1978 0.96
15 Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice. J Virol 1979 0.95
16 Naturally occurring humoral immunity to murine mammary tumor virus (MuMTV) and MuMTV GP52 in mice with low mammary tumor incidence. Int J Cancer 1978 0.92
17 Mouse mammary tumor virus and murine leukemia virus cell surface antigens on virus producer and nonproducer mammary epithelial tumor cells. Virology 1978 0.88
18 Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates. J Virol 1978 0.87
19 Host-cell lysosomal response to two strains of herpes simplex virus. J Virol 1970 0.86
20 Simian tumor virus isolate: demonstration of cytopathic effects in vitro. Science 1971 0.86
21 Squirrel monkey retrovirus: electron microscopy of a virus from New World monkeys and comparison with Mason-Pfizer monkey virus. Arch Virol 1978 0.84
22 Cell culture factors influencing in vitro expression of mouse mammary tumor virus. In Vitro 1976 0.82
23 Oncogenicity of murine mammary tumor virus produced in tissue culture: brief communication. J Natl Cancer Inst 1978 0.80
24 Characterization of infection and replication of Mason-Pfizer monkey virus in human cell cultures. J Gen Virol 1979 0.80
25 Expression of natural antibodies against endogenous and horizontally transmitted macaque retroviruses in captive primates. Virology 1981 0.80
26 Surface localization of virus production on a glucocorticoid-stimulated oncornavirus-producing mouse mammary tumor cell line by scanning electron microscopy. Cancer Res 1976 0.80
27 Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice. J Natl Cancer Inst 1978 0.78
28 Transformation of rhesus foreskin cells by Mason-Pfizer monkey virus. J Natl Cancer Inst 1972 0.78
29 Biologic characteristics of transformed rhesus foreskin cells infected with Mason-Pfizer monkey virus. J Natl Cancer Inst 1974 0.78
30 Features of cross protection between Sindbis and Venezuelan equine encephalitis viruses in mice--relationship of route of immunization to protection. J Gen Virol 1974 0.77
31 Type D retroviruses: occurrence of natural antibodies to Mason-Pfizer monkey virus in rhesus monkeys. Virology 1978 0.77
32 Virus susceptibility of a new simian cell line of fetal origin. Appl Microbiol 1973 0.77
33 Natural distribution of squirrel monkey retrovirus proviral sequences in primate DNAs. J Gen Virol 1978 0.75
34 Contributions of the founders of Craig Colony to epileptology and public care of epileptics: 1890-1915. J Hist Neurosci 1995 0.75
35 Development of herpes simplex virus in the isolated nuclei of HEp-2 cells. I. Viability of isolated HSV-infected nuclei. Can J Microbiol 1972 0.75
36 Development of herpes simplex virus in the isolated nuclei of HEp-2 cells. II. Intranuclear events in isolated HSV-infected nuclei. Can J Microbiol 1972 0.75
37 Functionally conserved determinants on gp70s of endogenous primate retroviruses. Virology 1980 0.75
38 William P. Letchworth: philanthropist and pioneer epileptologist. Arch Neurol 1993 0.75
39 Immunological relationship between an oncornavirus isolate from HEp-2 cells, Mason-Pfizer monkey virus, and human tumor cells. Bibl Haematol 1975 0.75
40 Simian tumour virus proliferation in inoculated Macaca mulatta. Nat New Biol 1972 0.75
41 Three state health reform initiatives fail. Health Syst Rev 1994 0.75
42 Mason-Pfizer monkey virus and simian AIDS. Lancet 1984 0.75
43 The contributions of Dr. Roswell Park to epilepsy and spinal surgery. Neurosurgery 1998 0.75
44 Demonstration of components of serum-free culture medium effecting maximum in vitro expression of mouse mammary tumor virus. In Vitro 1978 0.75
45 The importance of Spratling. Arch Neurol 1994 0.75